---
figid: PMC6198389__10.1177_1533033818806910-fig3
figtitle: Possible therapeutic strategies for cancer stem cell elimination
organisms:
- Homo sapiens
- Macaca mulatta
- Callithrix jacchus
- marmosets
- Mus musculus
- Oryctolagus cuniculus
- Diaporthe sclerotioides
- Macrostomum sp.
organisms_ner:
- Homo sapiens
- Mus musculus
- Callithrix jacchus
- Macaca mulatta
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC6198389
filename: 10.1177_1533033818806910-fig3.jpg
figlink: /pmc/articles/PMC6198389/figure/fig3-1533033818806910/
number: F3
caption: Possible therapeutic strategies for cancer stem cell elimination. (1) Targeting
  surface protein biomarkers such as CD133 with the aim to develop CSC-specific therapies.
  (2) Inhibiting the role of efflux transporters to reduce resistance to cancer drugs.
  (3) Reprogramming CSCs to a normal state by altering their metabolism and inducing
  them to differentiate. (4) Inhibiting pathways essential for CSC proliferation such
  as the Wnt/β-catenin signaling pathway. (5) Affecting the vascular niche to impair
  microenvironmental mechanisms that regulate GSC maintenance and function. CSC indicates
  cancer stem cell; GSC, germinal stem cell.
papertitle: 'Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases:
  Its Promises, Obstacles, and Future Perspectives.'
reftext: Yousef M. Hawsawi, et al. Technol Cancer Res Treat. 2018;17:1533033818806910.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9377974
figid_alias: PMC6198389__F3
figtype: Figure
redirect_from: /figures/PMC6198389__F3
ndex: d18132fd-de95-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6198389__10.1177_1533033818806910-fig3.html
  '@type': Dataset
  description: Possible therapeutic strategies for cancer stem cell elimination. (1)
    Targeting surface protein biomarkers such as CD133 with the aim to develop CSC-specific
    therapies. (2) Inhibiting the role of efflux transporters to reduce resistance
    to cancer drugs. (3) Reprogramming CSCs to a normal state by altering their metabolism
    and inducing them to differentiate. (4) Inhibiting pathways essential for CSC
    proliferation such as the Wnt/β-catenin signaling pathway. (5) Affecting the vascular
    niche to impair microenvironmental mechanisms that regulate GSC maintenance and
    function. CSC indicates cancer stem cell; GSC, germinal stem cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ABCG2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - DHH
  - IHH
  - SHH
  - BTK
  - CD44
  - MTOR
  - ITGA6
  - Abcg2
  - Ctnnb1
  - Cd44
  - Mtor
  - Itga6
  - .na.character
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arm
  - atk
  - Tor
  - Cancer
---
